Ward 21 CRS
Welcome,         Profile    Billing    Logout  
 6 Trials 
14 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cohen, Sarah
PREVENTABLE, NCT04262206: Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

Recruiting
4
20000
US
Atorvastatin 40 Mg Oral Tablet, Lipitor, Placebo oral tablet
Duke University, National Institute on Aging (NIA), National Heart, Lung, and Blood Institute (NHLBI), Wake Forest University Health Sciences
Cognitive Impairment, Mild, Dementia, Cardiovascular Diseases
12/26
12/26
PATH-HHT, NCT03910244: Pomalidomide for the Treatment of Bleeding in HHT

Completed
2
145
US
Pomalidomide Oral Product, POMALYST, Placebo oral capsule
The Cleveland Clinic, RTI International
Telangiectasia, Hereditary Hemorrhagic
09/23
09/23
CARBON, NCT04035434: A Safety and Efficacy Study Evaluating CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies

Terminated
1/2
62
Europe, Canada, US, RoW
CTX110
CRISPR Therapeutics AG
B-cell Malignancy, Non-Hodgkin Lymphoma, B-cell Lymphoma, Adult B Cell ALL
10/24
10/24
CRSP-ONC-006, NCT05643742: A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Recruiting
1/2
120
US, RoW
CTX112
CRISPR Therapeutics AG
B-cell Lymphoma, Non-Hodgkin Lymphoma, B-cell Malignancy, Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL), Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Large B-cell Lymphoma
01/30
02/30
NCT04244656: A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

Hourglass Sep 2021 - Dec 2021 : Top-line data from trial for r/r multiple myeloma
Terminated
1
26
Europe, Canada, US, RoW
CTX120
CRISPR Therapeutics AG
Multiple Myeloma
01/24
01/24
Delany-Moretlwe, Sinead
HOPE II, NCT06436274: Efficacy of Human Papillomavirus (HPV) Vaccination to Prevent Infection Among Women Living With HIV.

Recruiting
4
750
RoW
GARDASIL®9, Menveo®/Menactra®
Massachusetts General Hospital, University of Witwatersrand, South Africa, Botswana Harvard Health Partnership, Ministry of Health, Rwanda, Fred Hutchinson Cancer Center, National Cancer Institute (NCI), Karolinska Institutet
Human Papilloma Virus, Hiv
04/26
06/27
HPTN 084, NCT03164564: Evaluating the Safety and Efficacy of Long-Acting Injectable Cabotegravir Compared to Daily Oral TDF/FTC for Pre-Exposure Prophylaxis in HIV-Uninfected Women

Active, not recruiting
3
3224
RoW
Oral CAB, Cabotegravir, Oral TDF/FTC, Tenofovir disoproxil fumarate/emtricitabine, Truvada, Placebo for oral CAB, Placebo for oral TDF/FTC, CAB LA, Cabotegravir long-acting injectable, Placebo for CAB LA
National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
11/20
11/24
NCT06446752: BIYELA - Bexsero Immunisation in Young Women in Africa

Not yet recruiting
3
1100
RoW
Bexsero, 4MenB-4C, Placebo, Saline
University of Washington, Bill and Melinda Gates Foundation, University of Witwatersrand, South Africa
Gonorrhea, Gonorrhea of Pharynx, Gonorrhea of Anus, Gonorrhea of Cervix
05/26
08/26
HVTN143, NCT05959707: Evaluating the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibodies in Healthy Participants

Suspended
1
77
RoW
VRC01.23LS, PGT121.414.LS, PGDM1400LS
HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
01/25
01/25
NCT04038060: The PrEP (Pre-exposure Prophylaxis) SMART Study

Completed
N/A
350
RoW
WhatsApp Group, 2-way SMS, Drug level feedback, Monthly counseling sessions
University of Washington, Wits Reproductive Health and HIV Institute, National Institute of Mental Health (NIMH)
HIV/AIDS
10/21
01/22
INSIGHT, NCT05746065: A Cohort for Evaluation of Open-label PrEP Use and PreP Preferences Among African Women

Completed
N/A
3087
RoW
PrEP, Truvada
University of Washington, Bill and Melinda Gates Foundation
HIV Infections
08/23
08/23
NCT05664490: Friendship Bench Mental Health Intervention for Adolescent Girls and Young Women in South African PrEP Delivery Settings

Recruiting
N/A
110
RoW
Youth Friendship Bench SA
University of California, San Francisco, National Institute of Mental Health (NIMH), University of Witwatersrand, South Africa
Depression, Pre-Exposure Prophylaxis
02/25
02/25
Leader, CRS
HVTN 135, NCT04607408: Evaluating Safety and Immune Response to the HIV-1 CH505 Transmitted/Founder gp120 Adjuvanted With GLA-SE in Healthy, HIV-exposed Uninfected Infants

Completed
1
38
RoW
CH505TF gp120, GLA-SE adjuvant, Placebo
HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID)
HIV Infections
07/24
07/24
NCT04860323: Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study

Active, not recruiting
N/A
13
RoW
Analytical Treatment Interruption
HIV Vaccine Trials Network, National Institute of Allergy and Infectious Diseases (NIAID), HIV Prevention Trials Network, Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
HIV Infection
02/25
02/25
Naidoo, Ishana
No trials found

Download Options